Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Pyramax in Mild to Moderate COVID-19
KCT0005834Phase 2Completed
- Sponsor
- Shinpoong Pharma
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyronaridine in coronavirus disease 2019 (COVID-19), sponsored by Shinpoong Pharma. Started Aug 2020; status: completed.
02
Drugs
pyronaridine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on KCT0005834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005834.